V.P. Podpalov, N.S. Balashenko
Cardiovascular system remodelling and biochemical parameters in patients with arterial hypertension of the 1st-2nd degree combined with atherosclerotic lesion of carotid arteries
Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Vitebsk, Republic of Belarus
Objectives. To study the cardiovascular system remodelling and biochemical parameters in patients with hypertension (HT) of the 1st-2nd degree in association with atherosclerotic lesion of carotid arteries.
Material and methods. 265 patients (190 persons with HT of the 1st-2nd degree and 75 practically healthy subjects) were examined. 120 patients with HT of the 1st-2nd degree had atherosclerotic plaques in their carotid arteries. The data from the standard questionnaire, office BP measurement, ambulatory blood pressure monitoring, electrocardiography (ECG), Holter ECG monitoring, echocardiography, carotid arteries ultrasound investigation, pulse wave velocity definition, biochemical serum and urine data (lipid parameters, C-reactive protein, glucose, creatinine and microalbumin) were evaluated.
Results. Patients with HT of the 1st-2nd degree in association with carotid atherosclerotic plaques had more expressed changes in the heart and vessels remodelling processes which were determined according to the results of echocardiography, Holter ECG monitoring, ultrasound investigation of the carotid arteries. It was also found that patients with HT of the 1st-2nd degree in association with carotid atherosclerotic plaques had more expressed changes in biochemical parameters of blood serum in the form of higher levels of total cholesterol, triglycerides, low density lipoprotein cholesterol, C-reactive protein compared with the group of patients with HT of the 1st-2nd degree without atherosclerotic plaques in their carotid arteries.
Key words: arterial hypertension, remodelling, cardiovascular system, atherosclerotic plaques of carotid arteries.
1. Alexander RW. Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995 Feb;25(2):155-61.
2. Klijn CJ, Kappelle LJ, van Huffelen AC, Visser GH, Algra A, Tulleken CA, van Gijn J. Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology. 2000 Dec;55(12):1806-12.
3. Chobanian AV, Alexander RW. Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications. Arch Intern Med. 1996 Sep;156(17):1952-6.
4. Herder M, Johnsen SH, Arntzen KA, Mathiesen EB. Risk factors for progression of carotid intimamedia thickness and total plaque area: a 13-year follow-up study: the Tromsø Study. Stroke. 2012 Jul;43(7):1818-23.
5. Kotovskaya YuV, Kobalava ZhD. Osnovnye rezul'taty issledovaniia ELSA [Main results of the research ELSA]. Kachestv. klin. praktika. 2002;(4):23-33.
6. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M,Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P,Viigimaa M, Waeber B, Zannad F. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357.
7. Sehestedt T, Jeppesen J, Hansen TW, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt P, Olsen MH. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010 Apr;31(7):883-91.
8. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, Volcik K, Boerwinkle E, Ballantyne CM. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol. 2010 Apr;55(15):1600-7.
9. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004 Apr;43(4):731-8.
10. Pavlova OS, Nechesova TA. Tipy remodelirovaniia miokarda levogo zheludochka pri arterial'noi gipertenzii i vozmozhnosti medikamentoznoi korrektsii [Types of remodeling of a myocardium of a left ventricle at arterial hypertension and possibility of medicamental correction]. Med. panorama. 2002;(6):5-8.
11. Preobrazhensky DV, Sidorenko BA, Alekhin MN, Batyraliev TA, Stetsenko TM. Gipertrofiia levogo zheludochka pri gipertonicheskoi bolezni. Chast' II. Prognosticheskoe znachenie gipertrofii levogo zheludochka [A hypertrophy of a left ventricle at an idiopathic hypertensia. Part II. Prognostic value of a hypertrophy of a left ventricle]. Kardiologiia. 2003;(11):98-101.
12. Podzolkov VI, Bulatov VA. Miokard. Nefron. Vzgliad cherez prizmu evoliutsii arterial'noi gipertenzii [Myocardium. Nephron. A view through a prism of evolution of arterial hypertension]. Rus. med. zhurn. 2008;(16):1517-23.
13. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol. 2004 Feb;43(3):317-27.
14. Ridker PM. High-sensitive C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001 Apr;103(13):1813-8.
15. Koenig W, Sund M, Fröhlich M, Fischer HG, Löwel H, Döring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predict future risk of coronary heart disease in initially healthy middle-aged men: results from MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort study, 1984 to 1992. Circulation. 1999 Jan;99(2):237-42.